Sysmex Stock

Sysmex EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Sysmex (6869.T) as of Sep 6, 2026 is 20.94. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 58.73 — a change of -64.35% (lower).

EV/FCF

20.94

YoY

-64.35%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Sysmex is 2026 20.94 . EV/FCF (Enterprise Value to Free Cash Flow) of Sysmex was 2025 58.73 . It decreases by -64.35% lower compared to the previous year.

The Sysmex EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
28.86 JPY
Jan 1, 2019
48.73 JPY
Jan 1, 2020
29.67 JPY
Jan 1, 2021
25.12 JPY
Jan 1, 2022
28.97 JPY
Jan 1, 2023
29.58 JPY
Jan 1, 2024
58.73 JPY
Jan 1, 2025
20.94 JPY
The Sysmex EV/FCF history
YEAREV/FCFYoY
20.94-64.35%
58.73+98.54%
29.58+2.10%
28.97+15.32%
25.12-15.32%
29.67-39.12%
48.73+68.85%
28.86-48.52%
56.06+43.35%
39.10+11.56%
35.05-13.72%
40.62
Access this data via the Eulerpool API

Sysmex Stock analysis

What does Sysmex do? Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sysmex stock

EV/FCF (Enterprise Value to Free Cash Flow) of Sysmex is 20.94 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Sysmex changed from 58.73 to 20.94, representing a -64.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Sysmex since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Sysmex with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Sysmex

All Key Metrics — Sysmex